Kurt A. Gustafson
2011 - Halozyme Therapeutics
Compensation breakdown
Non-Equity Incentive Plan | $95,000 |
---|---|
Option Awards | $170,788 |
Salary | $320,850 |
Stock Awards | $160,080 |
Other | $7,675 |
Total | $754,393 |
Gustafson received $320.9K in salary, accounting for 43% of the total pay in 2011.
Gustafson also received $95K in non-equity incentive plan, $170.8K in option awards, $160.1K in stock awards and $7.7K in other compensation.
Rankings
In 2011, Kurt A. Gustafson's compensation ranked 6,667th out of 10,747 executives tracked by ExecPay. In other words, Gustafson earned more than 38.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,667 out of 10,747 | 38th |
Division Manufacturing | 2,418 out of 3,960 | 39th |
Major group Chemicals And Allied Products | 572 out of 1,033 | 45th |
Industry group Drugs | 377 out of 781 | 52nd |
Industry Biological Products, Except Diagnostic Substances | 58 out of 157 | 63rd |
Gustafson's colleagues
We found six more compensation records of executives who worked with Kurt A. Gustafson at Halozyme Therapeutics in 2011.
2011
James Shaffer
Halozyme Therapeutics
Vice President and Chief Commercial Officer
2011
Jean Liu
Halozyme Therapeutics
General Counsel
2011
William Fallon
Halozyme Therapeutics
Vice President, Manufacturing & Operations
2011
H Shepard
Halozyme Therapeutics
Chief Scientific Officer
2011
Gregory Frost
Halozyme Therapeutics
Chief Executive Officer
2011
David Ramsay
Halozyme Therapeutics
Chief Financial Officer
News
April 26, 2024
May 1, 2023
April 27, 2022
April 22, 2020
April 23, 2019